Sun Pharma is India’s largest pharmaceutical company by market presence and has a strong global footprint. Alongside its large generics portfolio, the company has been increasing its focus on specialty and branded products, especially in dermatology and ophthalmology. This shift aims to improve margins and reduce dependence on commoditized generics. Sun Pharma’s performance is influenced by regulatory developments, market competition, and new product launches. Its scale, brand strength, and specialty pipeline play a key role in shaping its long-term business profile. Disclaimer: Investments in securities are subject to market risk. This is for educational purposes ***** must verify information before investing and consider their financial position & risk profile. please read full disclosure disclaimer in given link

#WatchOutFor

629 likes·45 comments